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Abstract
Background: Semen armeniacae amarum (SAA) is a Chinese traditional medicine and has long
been used to control acute lower respiratory tract infection and asthma, as a result of its
expectorant and antiasthmatic activities. However, its mutagenicity in vitro and in vivo has not yet
been reported. The Ames test for mutagenicity is used worldwide. The histidine contained in
biological samples can induce histidine-deficient cells to replicate, which results in more his+
colonies than in negative control cells, therefore false-positive results may be obtained. So, it
becomes a prerequisite to exclude the effects of any residual histidine from samples when they are
assayed for their mutagenicity. Chinese traditional herbs, such as SAA, are histidine-containing
biological sample, need modified Ames tests to assay their in vitro mutagenicity.
Methods: The mutagenicity of SAA was evaluated by the standard and two modified Ames tests.
The first modification used the plate incorporation test same as standard Ames teat, but with new
negative control systems, in which different amounts of histidine corresponding to different
concentrations of SAA was incorporated. When the number of his+ revertants in SAA experiments
was compared with that in new negative control, the effect of histidine contained in SAA could be
eliminated. The second modification used a liquid suspension test similar to the standard Ames test,
except with histidine-rich instead of histidine-limited medium. The aim of this change was to
conceal the effect of histidine contained in SAA on the final counting of his+ revertants, and
therefore to exclude false-positive results of SAA in the Ames test. Furthermore, the effect of SAA
on chromosomal aberration in mammalian bone marrow cells was tested.
Results: The standard Ames test showed a positive result for mutagenicity of SAA. In contrast, a
negative response was obtained with the modified plate incorporation and modified suspension
Ames tests. Moreover, no apparent chromosomal aberrations were observed in mammalian bone
marrow cells treated with SAA.
Conclusion: The standard Ames test was not suitable for evaluating the mutagenicity of SAA,
because false-positive result could be resulted by the histidine content in SAA. However, the two
modified Ames tests were suitable, because the experimental results proved that the effect of
histidine in SAA and therefore the false-positive result were effectively excluded in these two
modified Ames tests. This conclusion needs more experimental data to support in the future.
Moreover, the experimental results illustrated that SAA had no mutagenicity in vitro and in vivo. This
was in agreement with the clinical safety of SAA long-term used in China.
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Background
Semen Armeniacae amarum (SAA) has long been used in
Chinese traditional medicine to control acute lower respi-
ratory tract infection and asthma as a result of its expecto-
rant and antiasthmatic activities [1]. Do has reported that
SAA had antiasthmatic activity and selectively inhibited
the type 2 helper T cell response in a mouse model [2].
Liang and Nie have investigated the effects of processing
on special toxicity and pharmacodynamics of SAA, and
have found that parching after scalding is the best method
for enhancing bowel relaxation, inactivating amygdalase,
and increasing the decoction rate of amygdalin [3,4].
Microwaves are also a good processing method [5]. The
toxicity of SAA is rooted mainly in amygdaloside, which is
reduced by amygdalase. Therefore, the potential cytotox-
icity and genotoxicity of SAA should be paid more atten-
tion, but there has been a lack of experimental evidence
until now [6-9]. In the present assay, the genotoxicity of
SAA was evaluated by the standard and two modified
Ames tests, and by the mammalian bone marrow chromo-
somal aberration test.
The standard Ames test for mutagenicity evaluation is
used worldwide [10]. The bacteria used in the Ames test
are mutant strains of Salmonella typhimurium, which carry
a defective gene (his-) that makes them unable to synthe-
size histidine from the culture medium. However, such
mutations can be reversed, with the gene regaining its
function, and these revertants (his+) are able to grow on
medium that lacks histidine. Therefore, the amount of
histidine or histidine-related compounds in the test
media is the main factor that influences the results of the
standard Ames test [11,12].
The effects of histidine and histidine-related precursors on
the induction of revertants in S. typhimurium tester strains
in the plate incorporation test have been reported by
Aeschbacher et al [13] and Busch et al [14]. The fact that
histidine and its precursors can give false-positive results
in the Ames test by increasing the number of spontaneous
revertants has prompted studies of the modification of
this bioassay for histidine-containing biological samples
[15-19]. Chinese herbal medicines are histidine-contain-
ing biological samples, and their water extracts are taken
orally. When evaluating the mutagenicity of these water
extracts, the interference from histidine and its precursors
within the samples must be eliminated. One modified
method, which was successfully used for urine [17,18], is
not suitable for herbal medicine samples, because some
active ingredients in herbal medicines may be lost during
the extraction process. Other modifications use different
mutations [20-26], such as forward mutation to 8-azagua-
nine resistance in S. typhimurium TM6779 [20], reverse
mutation in Escherichia coli tryptophan-deficient strain
WP2 [21], or neomycin-resistant mutation in Vibrio har-
veyi [22,23], but all these modified methods lack interna-
tional guidelines. Liu and Jin have reported a modified
suspension test for estimating the mutagenicity of sam-
ples that contain histidine, which uses relative reversion
frequency (RRF) as a new criterion [26].
Here, we report two modified methods. The first one uses
the standard plate incorporation Ames test, but with a
new negative control system. The second one uses a liquid
suspension Ames test, but uses histidine-rich rather than
histidine-limited medium. The negative mutagenicity of
SAA evaluation by these two modified methods indicated
that the false-positive results obtained by the standard
Ames test were eliminated. Such results coincided with
the negative response of SAA in the mammalian bone
marrow chromosomal aberration test.
Methods
Bacterial strains
S. typhimurium strains TA100 and TA98 were provided by
the Shandong Center for Disease Control and Prevention
(Jinan, China).
Chemicals
Sodium azide (NaN3), 2-aminofluorene (2-AF), L-histi-
dine HCl, and D-biotin were purchased from Sigma-
Aldrich (St. Louis, MO, USA). All other chemicals were of
analytical reagent grade. Cytochrome P450 was provided
by the Institute of Toxicology Research, Shandong Prov-
ince Center for Disease Control and Prevention.
Media
Minimal medium: 10.5 g K2HPO4, 4.5 g KH2PO4, 0.1 g
MgSO4, 1.0 g (NH4)2SO4, 0.5 g trisodium citrate dehy-
drate, 2.0 g glucose, 20 mg D-biotin, 1000 mL distilled
water. Histidine-limited medium: minimal medium sup-
plemented with 5 μmol  L-histidine HCl. Histidine-rich
medium: minimal medium supplemented with 5 mmol
L-histidine HCl. Solid medium: 1000 mL liquid medium
that contained 15 g pure agar (Oxoid Ltd., Basingstoke,
Hampshire, UK).
SAA water extract
One hundred grams of processed dry SAA (Shandong
Jianlian Chinese Medical Co. Ltd., Jinan, China) was
soaked in 10 volumes of water for 1 h, boiled at 100°C for
30 min, and passed through a 40-mesh filter. The solids
were recovered and boiled in six volumes of water for 1 h,
and passed through a 40-mesh filter again. Both filtrates
were mixed together and concentrated in vacuo at 55-60°C
to a volume of 100 mL, and centrifuged at 12,000 g for 20
min. The supernatant was 1 g mL-1 SAA water extract,
which was autoclaved (30 min at 115°C) before storage at
-20°C.BMC Complementary and Alternative Medicine 2009, 9:43 http://www.biomedcentral.com/1472-6882/9/43
Page 3 of 8
(page number not for citation purposes)
Determining histidine concentration of SAA water extract
The concentration of histidine in SAA was determined in
three stages, as described previously [27].
Sample preparation. Five milliliters of SAA water extract
and 5 mL 12 M HCl were added to a tube with screw plug,
along with three or four drops of distilled phenol. The
tube was refrigerated in cryogen for 3-5 min, vacuumized
to around 0 Pa, and filled with pure nitrogen. The latter
two steps were repeated three times, screwed the tube
when filled nitrogen at the last time, and the sample was
hydrolyzed in a thermostatic drying oven at 110 ± 1°C for
22 h. When cooled, the hydrolysate was filtrated, the tube
was washed several times with deionized water, and the
filtrate was collected. Deionized water was added to the
filtrate to a volume of 50 mL. One milliliter was trans-
ferred to a volumetric tube and dried in a vacuum dryer at
40-50°C. Added 1-2 mL deionized water into the tube
and then dried again, and this process was repeated twice.
Finally, added 1 mL sodium citrate buffer (pH 2.2) into
the tube to dissolve the remnant, the solusion was used
for total histidine determination. For free histidine deter-
mination, the hydrolysate was replaced by 5 mL SAA
water extract, and the other procedures were the same as
above.
Amino acid determination. Amino acid mixture (0.2 mL)
was added to a new tube with screw plug and sodium cit-
rate buffer (pH 2.2) was added to a final volume of 5 mL.
This was used as an amino acid mixture standard solution,
with an amino acid concentration of 5.00 nmol/50 μL.
The histidine concentration of SAA samples was deter-
mined with an external standard method using a BIO-
CHROM 30 (GE Healthcare, USA) automatic amino acid
analyzer.
Histidine concentration calculation
The calculation formula was:  . X  is the
content of histidine in the SAA sample (μg g-1); c is the
content of histidine in the amino acid mixture standard
solution (nmoL/50 μL); V is the ...constant volume of the
sample after hydrolysis (mL); M is histidine molecular
weight (155.2); m is the mass of the sample (g); 1/50 was
used to convert to content of histidine per milliliter of
sample (μmol L-1); 103 was used to convert ng to μg.
Mutagenicity assay of SAA by the standard and first 
modified Ames tests
A total of 1.5 × 108-2.0 × 108 exponentially growing cells
of strain TA100 or TA98 were coated onto histidine-lim-
ited medium plates. If nothing was incorporated, they
belonged to the standard negative control group. If muta-
gens were present, they belonged to the positive control
group. If different concentrations of SAA were incorpo-
rated, they belonged to the SAA treatment group. If differ-
ent amounts of L-histidine HCl corresponding to different
amounts of SAA water extract were incorporated, they
belonged to the newly modified negative control group.
The identification of mutagens and non-mutagens in the
standard Ames test was based on the ratio of the number
of revertants in the SAA treatment groups to that in the
negative control groups. If the ratio was ≥2 and dose-
dependent, the SAA had mutagenicity. The identification
of mutagens and non-mutagens in the first modified
Ames test was based on the ratio of the number of rever-
tants in the SAA treatment groups to that in the newly
modified negative control groups. If the ratio was ≥2 and
dose-dependent, the SAA had mutagenicity.
Mutagenicity assay of SAA by the second modified Ames 
test
In the second modified Ames test (suspension test), a total
of 1.5 × 108-2.0 × 108 exponentially growing cells of strain
TA100 or TA98 in 0.5 mL culture were transferred into test
tubes that contained 4.5 mL histidine-rich medium. The
latter replaced the histidine-limited medium that was
used in the standard suspension Ames test. If nothing was
added in the tubes, the experiments belonged to the neg-
ative control group. If mutagen was added, the experi-
ments belonged to the positive control group. If different
concentrations of SAA were added, the experiments
belonged to the SAA treatment groups. After the test tubes
were incubated at 37°C for 4 h, the cells were washed
twice and resuspended in 5 mL sterile saline solution
(0.9% NaCl), and 0.1 mL such suspension was transferred
to the minimal medium plates to count the number of his+
revertants.
The identification of mutagens and non-mutagens in this
modified suspension Ames test based on the ratio of the
number of revertants in the SAA treatment groups to that
in the negative control groups. If the ratio was ≥2 and
dose-dependent, the SAA had mutagenicity.
Mammalian bone marrow cell chromosomal aberration 
test
The mammalian bone marrow cell chromosomal aberra-
tion test was done by the Institute of Toxicology Research,
Shandong Province Center for Disease Control and Pre-
vention, according to the national standards of the Peo-
ple's Republic of China [28]. The experimental mice were
provided by the Institute of Laboratory Animal Science,
Chinese Academy of Medical Sciences. Fifty male SPF
Kunming mice [Production license No. SCXK-(Beijing)
2004-0001], 7-8 weeks of age and weighing 25-30 g, were
used for the five experimental groups. The mice were fed
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in Shielding environment [the permit No. for the use of
laboratory animals was SYXK-(Shandong) 20030006].
The Animal feed was provided by the Experimental Ani-
mal Center of Shandong Province [Production license No.
SCXK-(Shandong) 2004-0014]. The mice were divided
randomly into five groups of 10 mice each as follows: ster-
ile saline solution (0.9% NaCl), negative control group;
cyclophosphamide-treated (40 mg kg-1), positive control
group; and three groups treated with 125, 250 or 500 mg
mL-1, respectively. Each SAA dose was administered at a
volume of 0.02 mL g-1 body weight (BW) by oral gavage,
three times at 24-h intervals. The same amount of sterile
saline solution was used as a solvent control; mice in the
positive control group were given a single intraperitoneal
injection of cyclophosphamide dissolved in sterile saline
solution at a dose of 40 mg kg-1 BW. Six hours before sac-
rifice by cervical dislocation 24 h after the final treatment,
all mice received a single intraperitoneal injection of col-
chicine dissolved in sterile saline solution at a dose of 4
mg kg-1 BW. Bone marrow smears were prepared, stained
with Giemsa stain, and examined by microscopy. For each
mouse, 100 cells were examined to determine the fre-
quency of chromosomal aberrations in bone marrow. Dif-
ferences in the frequencies of chromosomal aberration
between the groups were assessed by the χ2 test (SPSS
12.0), with statistical significance set at P < 0.05.
Results
Effect of histidine concentration on growth of his- cells and 
number of his+ revertants
The effect of histidine concentration on growth of his-
TA100 cells in minimal medium is shown in Fig. 1. The
maximum growth rate of TA100 cells appeared with the
highest concentration of histidine (100 nM) in the
medium. The number of his+ revertants followed a sig-
moid curve, which approached a saturated asymptote that
was best fitted by a logistic growth equation, as shown in
Fig. 2.
Mutagenicity of SAA in the standard Ames test
The mutagenicity of SAA was tested using TA98 and
TA100 as indicator strains in the standard Ames test (Fig.
3). These results indicated that the number of his+ rever-
tants in the SAA groups was much higher than that in the
negative control group, and SAA increased the number of
his+ revertants in a dose-dependent manner, and therefore
resulted in a positive response in the standard Ames test.
Mutagenicity of SAA in the first modified Ames test
The experimental data shown in Figs. 1 and 2 indicated
that the number of his+ revertants obtained in the standard
Ames test was dependent on the concentration of histi-
dine in the testing medium. The concentration of histi-
dine in SAA is given in Table 1. Therefore, when
evaluating the mutagenicity of SAA, some histidine inevi-
tably was introduced into the testing medium. Such histi-
dine may have led to an increase in the number of his+
revertants, which gave a false-positive result. The results
obtained with the standard and first modified Ames tests
are shown in Figs. 3 and 4. These results demonstrated
clearly that the positive response of SAA in the standard
Ames test was an artefact.
All the ratios of the number of his+ revertants per plate in
the SAA group to that in the standard negative control
group were >2 (Table 1, column C/A), but for the newly
Growth curves of TA100 cells in minimal medium that con- tained different concentrations of histidine Figure 1
Growth curves of TA100 cells in minimal medium 
that contained different concentrations of histidine. 
Data are expressed as means ± SD of three individual exper-
iments.
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Number of his+ revertants per plate increased exponentially  with the histidine concentration in the medium Figure 2
Number of his+ revertants per plate increased expo-
nentially with the histidine concentration in the 
medium. Broken line: experimental data. Solid line: sigmoi-
dal fit curve by Origin 6.0, model Boltzmann.
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modified negative control group, the ratios were <2 (Table
1, columns C/B and C/b). B and b expressed the number
of his+ in the new negative controls - histidine content pre-
sented in the test plates corresponded to the free histidine
content of SAA (columns B) and total histidine (columns
b), respectively.
Mutagenicity of SAA in the second modified Ames test
Compared to the standard Ames test, the first modified
Ames test increased the workload and the cost, such that
another modification was used. It was based on the fact
that, using histidine-rich medium, a small amount of his-
tidine in SAA would not significantly increase the number
of his+ revertants. The results using this method are shown
in Fig. 4. At all the tested concentrations of SAA, the
number of his+ revertants was not significantly increased
compared to that of the negative control.
Chromosomal aberrations in mammalian bone marrow 
cells caused by SAA
The number of chromosomal aberrations in mammalian
bone marrow cells (for all three SAA doses) was not
increased significantly compared to that of the negative
control, but it was increased by positive control(cyclo-
phosphamide) (Table 2). This suggested that SAA had no
effect on inducing chromosomal aberrations in mamma-
lian bone marrow cells.
SAA showed a positive response in the standard Ames test Figure 3
SAA showed a positive response in the standard Ames test. Positive control of TA100 was 0.5 μg ml-1 NaN3, of TA98 
was 0.5 μg ml-1 2-AF.
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Table 1: Mutagenicity of SAA obtained by the modified Ames test with TA100*
SAA concentration (mg mL-1) Free (total) histidine in SAA (μg g-1)# his+ his+ C/A C/B C/b
1000 35.4 (233.4) - - - - -
125 7.65 (15.90) 921B(1218b)1 5 2 9 C 14.42 1.66 1.26
62.5 3.78 (7.95) 658B(965b) 843C 7.95 1.28 0.87
31.25 1.89 (3.875) 526B(673b) 796C 7.51 1.51 1.18
15.625 0.945 (1.94) 461B(494b) 704C 6.64 1.53 1.43
7.812 0.47 (0.097) 428B(477b) 532C 5.02 1.24 1.12
3.906 0.24 (0.049) 412B(406b) 271C 2.56 0.66 0.67
0 0 106A
Positive control 795
* TA100 positive control was 0.5 μg mL-1 NaN3.
# Histidine concentration was measured using BIOCHROM 30.
A: number of his+revertants per plate in the standard negative control. B: Number of his+ revertants per plate in the modified negative control (I), 
test medium contained the same amount of histidine as the free histidine in SAA. b: Number of his+ revertants per plate in the modified negative 
control (II), test medium contained the same amount of histidine as the total histidine in SAA. C: Number of his+ revertants per plate in the SAA 
treatment group.BMC Complementary and Alternative Medicine 2009, 9:43 http://www.biomedcentral.com/1472-6882/9/43
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Discussion
Modifications of the Ames test
In the Ames test, external free and/or protein-bound histi-
dine in biological samples induces his- tester strains to
grow more than negative controls, which results in more
his+ revertants and false-positive results. The data in figure
1 was a good example. This result was compatible with the
reported by Nylund et al [16]. Therefore, it is necessary to
exclude the effects of histidine in samples on the results of
mutagenicity assays [16-18,22,23]. The present study used
two modified Ames tests. The strategy of the first modifi-
cation was to eliminate the effect due to the histidine in
SAA. There are two features of this method that are worth
noting. First, there was an extra set of modified negative
control systems, in which different amounts of histidine,
which corresponded to those in the tested herbal medi-
cine, were added to the test medium. Second, when esti-
mating the mutagenicity of herbal medicines, his+
revertants from the negative control in the standard Ames
test was replaced by those from the newly modified nega-
tive control. The strategy of the second modification was
to conceal the effect due to the histidine in SAA. It used a
suspension test, in which histidine-rich medium was used
to replace the histidine-limited medium of the standard
Ames test.
Comparison of the two modified Ames tests
Both of the modified Ames test in the present study could
exclude false-positive results of the mutagenicity of SAA,
but the first modification had some disadvantages. Firstly,
this method was more laborious and costly, because it
required measurement of the histidine concentration of
herbal medicines, and extra modified negative control sys-
tems. Secondly, sometimes it was difficult to obtain con-
clusive results. This was because different amounts of
histidine were used for the modified negative control test-
ing media: one group according to the free histidine in
SAA, and the other according to the total histidine in SAA.
The confusion arose because we did not know how much
of the protein-bound histidine in SAA could be used to
support his- cell growth, along with free histidine. The data
in table 1 indicated, all the ratios of the his+ numbers from
the SAA treatment groups to those from modified negative
control groups-by free and by total histidine (C/B and C/
b column in table 1) <2, so, negative doubtless results for
mutagenicity of SAA could be get. On the assumption
that, if C/B ≥ 2, and C/b ≥ 2, positive doubtless results for
mutagenicity of SAA could be get, too. However, if C/B ≥
2, but C/b < 2, it was difficult to obtain conclusive results.
Mutagenicity of SAA
The mutagenicity and genotoxicity of some Chinese
herbal medicines have been studied [6-10]. However, the
mutagenicity of SAA has not yet been investigated. Evalu-
ation of the mutagenicity of SAA using the two modified
Ames tests indicated that the false-positive results
Mutagenicity of SAA for strain TA98 using the second modi- fied Ames test Figure 4
Mutagenicity of SAA for strain TA98 using the sec-
ond modified Ames test. Positive control of TA100 was 
0.5 μg ml-1 NaN3, of TA98 was 0.5 μg ml-1 2-AF.
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Table 2: Frequency of chromosomal aberrations in bone marrow cells from mice treated by SAA
Treatment Chromosomal aberration Aberrations per 100 cells
G' G" B' B" Total
Control (water) 14 0 5 0 19 1.9 ± 0.88
CTX (40 mg kg-1) 47 4 258 2 311 31.1 ± 1.56**
SAA (g kg-1)
2.5 12 0 7 0 19 1.91 ± 1.37
5.0 14 1 8 0 23 2.3 ± 0.67
10.0# 10 0 7 0 17 1.7 ± 0.95
The mice were sacrificed 6 h after treatment with colchicine. One hundred cells were analyzed per animal for a total of 1000 cells per treatment. 
CTX = cyclophosphamide; G' = chromatid gap; G" = chromosome gap; B' = chromatid break; B" = chromosome break.
**Significantly different vs the negative control (P < 0.01, χ2 test).
# The highest SAA dose was nearly the maximum tolerated dose.BMC Complementary and Alternative Medicine 2009, 9:43 http://www.biomedcentral.com/1472-6882/9/43
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obtained by the standard Ames test were eliminated.
These results coincided with the negative response of SAA
in the mammalian bone marrow chromosomal aberra-
tion test, and with its clinical safety in long historical Chi-
nese medical practices.
Conclusion
The standard Ames test is not suitable for evaluating the
mutagenicity of Chinese traditional medicines such as
SAA. This is because the histidine and protein composi-
tion of these samples can increase the number of his+
revertants and lead to false-positive results. The two mod-
ified test methods can eliminate or cancel out the effect of
histidine in SAA on his+ revertants, and are suitable for
evaluating the mutagenicity of Chinese traditional medi-
cines, though need more experimental results to support.
In the present study, both modified methods gave, in con-
trast to the standard Ames test, negative results for the
mutagenicity of SAA. Such results were consistent with the
negative result for SAA in the mammalian bone marrow
chromosomal aberration test. These results together illus-
trated that SAA had no mutagenicity in vitro and in vivo.
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